Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management    » A1c    » Alcohol    » Alternative Medicine    » Beverages    » Care    » Cats    » Children    » Complications    » Control    » Dental    » Diet    » Dogs    » Drugs    » Education    » Elderly    » Environment    » Exercise    » Eye Care    » Family    » Food    » Foot Care    » Hearing    » Insulin    » Lifestyle    » Long-term    » Managing    » Men    » Minorities    » Monitor    » Nutrition    » Obesity    » Other Diseases    » Pets    » Pre-Diabetes    » Pregnancy    » Prevention    » Risks    » Salt    » Self-Management    » Sleep    » Smoking    » Spices    » Stress    » Sugar    » Supplements    » Technology    » Warning Signs    » Women Supplements Type 1 Warning Signs

 

 

 

     

Self-Management » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Diabetes Risk Falls as Magnesium Intake Increases Posted: Sunday, October 10, 2010

Getting enough magnesium in your diet could help prevent diabetes, a new study suggests. Consuming 200 milligrams of magnesium for every 1,000 calories reduces risk of diabetes by 47%.

EASD: Pioglitazone-Sitagliptin Combination Achieves Durable Glycemic Control Posted: Sunday, October 03, 2010

Adding 50 mg of sitagliptin (Januvia) to pioglitazone (Actos) allowed patients with Type 2 diabetes to achieve sustained glycemic control, a yearlong trial showed.

EASD: Type 2 Diabetes Less Prevalent in Women but Just as Deadly Posted: Sunday, October 03, 2010

Men are up to two and a half times more likely to have newly diagnosed Type 2 diabetes than women, but once a woman is diagnosed, the disease is just as deadly for them as for men.

EASD: Once-Weekly Exenatide Benefit Sustained over 52 Weeks Posted: Sunday, October 03, 2010

Once-Weekly Exenatide maintains a drop in A1c of 2 points for more than 52 weeks.

EASD: Moderate Wine Drinking Lowers Fasting Glucose in Type 2 Diabetes Posted: Sunday, October 03, 2010

A glass of merlot or perhaps sauvignon blanc with dinner may offer modest benefits for patients with Type 2 diabetes, said researchers.

EASD: Fracture Risk Demands Attention in Diabetes Patients Posted: Sunday, October 03, 2010

Because Type 2 diabetes weakens the bone in often undetectable ways, both directly and indirectly via treatment side effects, experts urged increased awareness.

EASD: Continuous Monitors May Miss Hypoglycemia Posted: Sunday, October 03, 2010

Continuous blood glucose monitors may not accurately detect low blood sugar, researchers found.

EASD: Frequent Hypoglycemia Key in Cardiac Risk Posted: Sunday, October 03, 2010

Patients with Type 1 diabetes who have repeated episodes of hypoglycemia appear to be at risk for early signs of atherosclerosis, researchers said.

EASD: Adding Incretin to Insulin Lowers HbA1c Posted: Sunday, October 03, 2010

Adding exenatide to insulin glargine for patients who aren't fully controlled with insulin glargine and/or other oral agents can help to improve their blood glucose.

New First in Class Type 2 Diabetes Drug Cycloset® Launches November Posted: Tuesday, September 21, 2010

VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes both as mono-therapy and in combination with other oral antidiabetic agents.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.